Expanded Reagent and Dye Portfolio for Cellular Analysis

BD Biosciences announced the launch of the BD™ Kaleidoscope reagent and dye expansion programme – marked by the initial release of nearly 200 new fluorochrome-conjugated antibodies for flow cytometry to help meet today’s life science research needs.

“Multicolour flow cytometry empowers researchers who are conducting complex experiments to analyse multiple parameters simultaneously, enhancing discovery and problem solving by providing them with a wealth of information in a single experiment,” said Jay Glasscock, President, Cell Analysis, BD Biosciences. “These 200 new products from the BD Kaleidoscope programme represent simply the beginning of our significant portfolio expansion designed to support the growing base of applications that can benefit from this powerful technology.”

The BD Kaleidoscope portfolio offers these new fluorochrome-conjugated antibodies in a full range of colours, making it easier to construct multicolour cocktails to obtain fluorescently separated cell populations more efficiently. In addition, researchers can choose from a wide range of sizes, such as the new 50 test/50mg size to reduce the cost of initial panel design and testing. The new BD reagents, like others in the BD Biosciences portfolio, are optimised for use with BD flow cytometry systems.

Information about the BD Kaleidoscope reagent and dye expansion programme can be found on the new and improved web site. Other enhancements include the new BD Cell Pathways tool, powered by Ingenuity systems, which allows researchers to explore pathways, find relevant information and optimise experiments.